Abstract
Plasma and saliva theophylline concentrations were measured in 21 asthmatic subjects receiving chronic oral therapy with a new sustained-release theophylline capsule (K1B Riker) given as a once daily dose, after titration to achieve a before-dose concentration of 8 mg l-1 or greater, or to the maximum dose of 1200 mg of theophylline daily. Plasma concentrations rose from a mean +/- s.d. minimum concentration (Cmin) of 7.9 +/- 2.3 mg l-1 to a mean maximum of 13.6 +/- 3.3 mg l-1 at a median time of 10 h after dosing. Saliva theophylline concentrations were closely related to the plasma theophylline concentration both between and within subjects with a mean saliva to plasma concentration ratio between subjects (S/P ratio) of 0.62 (+/- 0.05) and a mean within subject coefficient of variation of 8.2% (+/- 4.5%). There was a significant but small (10%) change in the mean S/P ratio during the dosing interval. Peak expiratory flow rate (PEFR) changed slightly but significantly during the dosing interval but forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) did not. The drug was well tolerated at the dose used (600-1200 mg once daily).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cusack B., Kelly J. G., Lavan J., Noel J., O'Malley K. Theophylline kinetics in relation to age: the importance of smoking. Br J Clin Pharmacol. 1980 Aug;10(2):109–114. doi: 10.1111/j.1365-2125.1980.tb01726.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Danhof M., Breimer D. D. Therapeutic drug monitoring in saliva. Clin Pharmacokinet. 1978 Jan-Feb;3(1):39–57. doi: 10.2165/00003088-197803010-00003. [DOI] [PubMed] [Google Scholar]
- Ebden P., Leopold D., Buss D., Smith A. P., Routledge P. A. Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction. Thorax. 1985 Jul;40(7):526–529. doi: 10.1136/thx.40.7.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ebden P., Leopold D., Smith A. P., Buss D., Routledge P. A. Free and total plasma theophylline concentrations in chronic airflow obstruction. Thorax. 1984 May;39(5):352–355. doi: 10.1136/thx.39.5.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gal P., Jusko W. J., Yurchak A. M., Franklin B. A. Theophylline disposition in obesity. Clin Pharmacol Ther. 1978 Apr;23(4):438–444. doi: 10.1002/cpt1978234438. [DOI] [PubMed] [Google Scholar]
- Hendeles L., Weinberger M., Milavetz G., Hill M., 3rd, Vaughan L. Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. Chest. 1985 Jun;87(6):758–765. doi: 10.1378/chest.87.6.758. [DOI] [PubMed] [Google Scholar]
- Jusko W. J., Gardner M. J., Mangione A., Schentag J. J., Koup J. R., Vance J. W. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci. 1979 Nov;68(11):1358–1366. doi: 10.1002/jps.2600681106. [DOI] [PubMed] [Google Scholar]
- Miksic J. R., Hodes B. Theophylline analysis by reversed-phase high-pressure liquid chromatography: elimination of interferences. J Pharm Sci. 1979 Sep;68(9):1200–1202. doi: 10.1002/jps.2600680946. [DOI] [PubMed] [Google Scholar]